Source:http://linkedlifedata.com/resource/pubmed/id/18951762
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2008-12-1
|
pubmed:abstractText |
Our goals in this study were to investigate conditions under which T cells from NOD mice express CD40 and to determine how CD40 on autoreactive CD4 T cells contributes to their pathogenicity in T1D. Using CD40-positive diabetogenic T cell clones and CD4 T cells from NOD mice, we examined expression of CD40 upon activation through the TCR and costimulation through either CD28 or CD40. Our results indicate that CD40 expression is increased upon activation with antigen/MHC and that activation of NOD CD4 T cells through TCR/CD40 rapidly induced CD40 expression. Furthermore, CD40 costimulation promoted T cell proliferation to the same extent as costimulation through TCR/CD28. Importantly, costimulation of CD4 T cells through CD40 also interfered with T cell homeostasis by altering regulation of CTLA-4 expression. Through CD40-CD154 blocking studies, we demonstrated that signaling between T cells through CD40 and its ligand contributes to activation of pathogenic T cells and that blocking CD40 on T cells abrogates their ability to transfer diabetes. Thus, costimulation through CD40 on NOD T cells contributes to their pathogenicity by providing additional pathways for activation and by inhibiting upregulation of CTLA-4 during T cell activation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD28,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD40,
http://linkedlifedata.com/resource/pubmed/chemical/CD40 Ligand,
http://linkedlifedata.com/resource/pubmed/chemical/CTLA-4 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Ctla4 protein, mouse
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0896-8411
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
385-92
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18951762-Animals,
pubmed-meshheading:18951762-Antibodies, Monoclonal,
pubmed-meshheading:18951762-Antigens, CD,
pubmed-meshheading:18951762-Antigens, CD28,
pubmed-meshheading:18951762-Antigens, CD40,
pubmed-meshheading:18951762-CD4-Positive T-Lymphocytes,
pubmed-meshheading:18951762-CD40 Ligand,
pubmed-meshheading:18951762-CTLA-4 Antigen,
pubmed-meshheading:18951762-Cell Line,
pubmed-meshheading:18951762-Cells, Cultured,
pubmed-meshheading:18951762-Diabetes Mellitus, Type 1,
pubmed-meshheading:18951762-Lymphocyte Activation,
pubmed-meshheading:18951762-Mice,
pubmed-meshheading:18951762-Mice, Inbred NOD,
pubmed-meshheading:18951762-Signal Transduction,
pubmed-meshheading:18951762-Up-Regulation
|
pubmed:year |
2008
|
pubmed:articleTitle |
CD40 on NOD CD4 T cells contributes to their activation and pathogenicity.
|
pubmed:affiliation |
Department of Immunology, University of Colorado at Denver and National Jewish Health, Denver, CO 80206, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|